In a report released today, Benjamin Theurer from Barclays maintained a Buy rating on Coca Cola Femsa SAB De CV, with a price target of $100.00. The company’s shares closed yesterday at $81.93.Elevate...
Here are three stocks added to the Zacks Rank #24 (Strong Sell) List today:Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has...
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has...
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:ATI Inc. ATI is a specialty manufacturing company. The Zacks Consensus Estimate for its current year earnings has been revised...
Fomento Economico Mexicano S.A.B. de C.V. FMX, alias FEMSA, stays on the list of investors’ favorite beverage stocks, mainly because of effective growth strategies and strong market demand. The company...
After a second straight losing week for stocks, investors in search of relative safety in the market might want to consider value-priced dividend stocks - like the three income picks we've highlighted...
Coca-Cola EuroPacific Partners offers emerging market exposure while trading at a discount to its parent and paying a higher yield.
Emerging markets could be spotlighted in 2024 due to outsized growth; here are 5 emerging market stocks that pay dividends and trade on US exchanges
Three foreign stocks, Takeda Pharmaceutical, United Microelectronics, and Coca-Cola FEMSA are showing that magical combination of growth and yield.
Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA) announced on Feb. 15 that it was changing course. As part of this strategic move, it will divest its remaining 14.76% stake in Heineken. What it plans...